These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23328224)
1. [The effect of inhaled anticholinergic drugs (tiotropium bromide) on asthma patients with persistent obstructive ventilatory impairment]. Nogami H; Honjo S; Iwanaga T Arerugi; 2012 Nov; 61(11):1675-82. PubMed ID: 23328224 [TBL] [Abstract][Full Text] [Related]
2. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
3. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD. Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356 [TBL] [Abstract][Full Text] [Related]
4. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients. Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992 [TBL] [Abstract][Full Text] [Related]
6. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N; Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228 [TBL] [Abstract][Full Text] [Related]
8. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan. Hsu JY; Perng RP; Lu JY; Wu CP; Huang MS; Luh KT; Yang PC J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618 [TBL] [Abstract][Full Text] [Related]
9. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. van Noord JA; Aumann JL; Janssens E; Smeets JJ; Verhaert J; Disse B; Mueller A; Cornelissen PJ Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868 [TBL] [Abstract][Full Text] [Related]
10. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study. Vogelberg C; Engel M; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Downie J; Nething K; Vevere V; Vandewalker M Respir Med; 2014 Sep; 108(9):1268-76. PubMed ID: 25081651 [TBL] [Abstract][Full Text] [Related]
12. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Bölükbas S; Eberlein M; Eckhoff J; Schirren J Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351 [TBL] [Abstract][Full Text] [Related]
13. Effects of short-acting bronchodilators added to maintenance tiotropium therapy. Kerstjens HA; Bantje TA; Luursema PB; Sinninghe Damste HE; de Jong JW; Lee A; Wijker SP; Cornelissen PJ Chest; 2007 Nov; 132(5):1493-9. PubMed ID: 17890476 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease]. Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma. Sposato B; Barzan R; Calabrese A; Franco C J Asthma; 2008 Jun; 45(5):397-401. PubMed ID: 18569233 [TBL] [Abstract][Full Text] [Related]
16. Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study. Di Marco F; Verga M; Santus P; Morelli N; Cazzola M; Centanni S Respir Med; 2006 Nov; 100(11):1925-32. PubMed ID: 16626956 [TBL] [Abstract][Full Text] [Related]
17. Improvements with tiotropium in COPD patients with concomitant asthma. Magnussen H; Bugnas B; van Noord J; Schmidt P; Gerken F; Kesten S Respir Med; 2008 Jan; 102(1):50-6. PubMed ID: 17920256 [TBL] [Abstract][Full Text] [Related]
18. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Koumis T; Samuel S Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812 [TBL] [Abstract][Full Text] [Related]
19. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids. Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333 [TBL] [Abstract][Full Text] [Related]
20. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness. Terzano C; Petroianni A; Ricci A; D'Antoni L; Allegra L Eur Rev Med Pharmacol Sci; 2004; 8(6):259-64. PubMed ID: 15745385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]